SCHEMBL4345797

SCHEMBL4345797

CS(=O)(=O)Nc1cc(Cl)cc(COc2c(Br)cc(CC(F)C(=O)O)cc2Br)c1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.34
THRA P10827 6/20 0.34
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
ALOX12 P18054 1/20 0.33
HTT P42858 1/20 0.33
ACLY P53396 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 2/20 0.32
FFAR1 O14842 1/20 0.32
CCR2 P41597 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
CYP2C9 P11712 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356784 0.87 THRA (0.40) THRBTHRAKDM4EALDH1A1CYP1A2
SCHEMBL5311039 0.87 THRA (0.40) THRBTHRAKDM4EALDH1A1CYP1A2
SCHEMBL4530626 0.86 THRB (0.35) THRBTHRALMNAKMT2ANPSR1
SCHEMBL4932175 0.86 THRB (0.39) THRBTHRALMNAKMT2ANPSR1
SCHEMBL4356861 0.83 THRB (0.39) THRBTHRAFFAR1TRPV1SMN1; SMN2
SCHEMBL5717998 0.81 THRB (0.36) THRBTHRALMNAKMT2ANPSR1
SCHEMBL5309606 0.80 THRA (0.38) THRBTHRAKDM4EALDH1A1CYP1A2
SCHEMBL14540614 0.80 THRA (0.38) THRBTHRAKDM4EALDH1A1CYP1A2
SCHEMBL4523460 0.78 THRB (0.38) THRBTHRAFFAR1
SCHEMBL5110782 0.77 CA1 (0.37) THRBTHRALMNAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRB 4/4885THRA 3/4885LMNA 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.